The Emerging Role of Poly (ADP-Ribose) Polymerase Inhibitors as Effective Therapeutic Agents in Renal Cell Carcinoma

por Pletcher, Jerred P., Bhattacharjee, Sayani, Doan, Jonathan P., Wynn, Rebecca, Sindhwani, Puneet, Nadiminty, Nagalakshmi, Petros, Firas G.
Publicado 2021

PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth

por Bhattacharjee, Sayani, Sullivan, Matthew J., Wynn, Rebecca R., Demagall, Alex, Hendrix, Andrew S., Sindhwani, Puneet, Petros, Firas G., Nadiminty, Nagalakshmi
Publicado 2022